Xenetic Biosciences, Inc. (XBIO)
1.72
-0.21
(-10.88%)
USD |
NASDAQ |
Oct 23, 16:00
1.71
-0.01
(-0.58%)
After-Hours: 20:00
Xenetic Biosciences Net Income (Quarterly) : -0.9297M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.9297M |
| March 31, 2026 | -0.4564M |
| December 31, 2025 | -0.5791M |
| September 30, 2025 | -0.5099M |
| June 30, 2025 | -0.6887M |
| March 31, 2025 | -0.9031M |
| December 31, 2024 | -1.054M |
| September 30, 2024 | -0.4367M |
| June 30, 2024 | -1.274M |
| March 31, 2024 | -1.195M |
| December 31, 2023 | -1.172M |
| September 30, 2023 | -1.056M |
| June 30, 2023 | -1.051M |
| March 31, 2023 | -0.8566M |
| December 31, 2022 | -1.482M |
| September 30, 2022 | -0.804M |
| June 30, 2022 | -2.672M |
| March 31, 2022 | -1.594M |
| December 31, 2021 | -1.842M |
| September 30, 2021 | -1.351M |
| June 30, 2021 | -1.107M |
| March 31, 2021 | -1.346M |
| December 31, 2020 | -1.20M |
| September 30, 2020 | -7.560M |
| June 30, 2020 | -0.9536M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.179M |
| December 31, 2019 | -1.170M |
| September 30, 2019 | -8.900M |
| June 30, 2019 | -1.377M |
| March 31, 2019 | -1.327M |
| December 31, 2018 | -1.639M |
| September 30, 2018 | -1.812M |
| June 30, 2018 | -2.026M |
| March 31, 2018 | -1.822M |
| December 31, 2017 | 4.445M |
| September 30, 2017 | -2.256M |
| June 30, 2017 | -2.919M |
| March 31, 2017 | -2.866M |
| December 31, 2016 | -0.3913M |
| September 30, 2016 | -2.472M |
| June 30, 2016 | -47.77M |
| March 31, 2016 | -3.572M |
| December 31, 2015 | -3.627M |
| September 30, 2015 | -5.324M |
| June 30, 2015 | -1.125M |
| March 31, 2015 | -2.431M |
| December 31, 2014 | -4.303M |
| September 30, 2014 | -3.182M |
| June 30, 2014 | -2.759M |
| March 31, 2014 | -4.063M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.6606M |
| Total Expenses (Quarterly) | 1.590M |
| EPS Diluted (Quarterly) | -0.4052 |
| Enterprise Value | -2.442M |
| Profit Margin (Quarterly) | -140.7% |
| Earnings Yield | -69.06% |
| Normalized Earnings Yield | -69.06 |